Publikationen von Martin Purrio

Malliou-Becher, M.-N.; Turnwald, E.-M.; Skupin, L.; Kretschmer, T.; Mesaros, A.; Purrio, M.; Wohlfarth, M.; Handwerk, M.; Kalis, S.; Gründermann, D. et al.; Dötsch, J.; Germeyer, A.; Appel, S.: Effect of metformin on the endometrial proteome of diet-induced obese mice. J Mol Endocrinol (2025)

Baghdadi, M.; Mesaros, A.; Purrio, M.; Partridge, L.: Sex-specific effects of Cre expression in Syn1Cre mice. Scientific Reports 13, 10037 (2023)

Janoschek, R.; Handwerk, M.; Hucklenbruch-Rother, E.; Schmitz, L.; Bae-Gartz, I.; Kasper, P.; Lackmann, J.-W.; Kretschmer, T.; Vohlen, C.; Mesaros, A. et al.; Purrio, M.; Quaas, A.; Dötsch, J.; Appel, S.: Heterogeneous effects of individual high-fat diet compositions on phenotype, metabolic outcome, and hepatic proteome signature in BL/6 male mice. Nutr Metab (Lond) 20 (8) (2023)

Srivastava, R. K.; Ruiz de Azua, I.; Conrad, A.; Purrio, M.; Lutz, B.: Cannabinoid CB1 Receptor Deletion from Catecholaminergic Neurons Protects from Diet-Induced Obesity. Int J Mol Sci 23 (20) (2022)

Allmeroth, K.; Hartman, M. D.; Purrio, M.; Mesaros, A.; Denzel, M. S.: Hexosamine pathway activation improves memory but does not extend lifespan in mice. Aging Cell, S. e13711 (2022)

Cui, D.; Mesaros, A.; Burdeos, G.; Voigt, I.; Giavalisco, P.; Hinze, Y.; Purrio, M.; Neumaier, B.; Drzezga, A.; Obata, Y. et al.; Endepols, H.; Xu, X.: Dnmt3a2/Dnmt3L Overexpression in the Dopaminergic System of Mice Increases Exercise Behavior through Signaling Changes in the Hypothalamus. Int J Mol Sci 21 (17), S. 6297 (2020)

Guggenhuber, S.; Alpar, A.; Chen, R.; Schmitz, N.; Wickert, M.; Mattheus, T.; Harasta, A. E.; Purrio, M.; Kaiser, N.; Elphick, M. R. et al.; Monory, K.; Kilb, W.; Luhmann, H. J.; Harkany, T.; Lutz, B.; Klugmann, M.: Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus. Brain Struct Funct 221 (4), S. 2061 - 74 (2016)

Stumm, C.; Hiebel, C.; Hanstein, R.; Purrio, M.; Nagel, H.; Conrad, A.; Lutz, B.; Behl, C.; Clement, A. B.: Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Neurobiol Aging 34 (11), S. 2574 - 84 (2013)

Rey, A. A.; Purrio, M.; Viveros, M. P.; Lutz, B.: Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 37 (12), S. 2624 - 34 (2012)